
Dr Dionysis Papadatos-Pastos | London Lung Oncologist
I am a London based oncologist, specialist in the treatment of lung cancer, mesothelioma and thymic tumors.

I offer my patients a personalized, compassionate approach rooted in my extensive experience as an oncologist. I tailor each treatment plan to the individual, ensuring the most effective therapies are used while considering each patient’s unique circumstances. The holistic approach emphasizes not only medical care but also emotional and psychological support, including guidance for family members throughout the cancer journey. My patients benefit from a dedicated team that understands the importance of comprehensive, family-centered cancer care.
Conditions treated
Comprehensive thoracic cancer treatment
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of cases. It includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC typically grows and spreads more slowly than small cell lung cancer. Early detection and treatment are crucial
Small Cell Lung Cancer
Small cell lung cancer (SCLC) is a fast-growing type of lung cancer that originates in the bronchi and quickly spreads to other parts of the body. It accounts for about 10-15% of all lung cancers. New treatments, including immunotherapy combined with chemotherapy, are showing promise in improving patient outcomes
Mesothelioma
Mesothelioma is a rare, aggressive cancer that develops in the mesothelium, the thin layer of tissue covering most internal organs, often linked to asbestos exposure1. New treatments, such as immunotherapy have been shown to improve survival rates and quality of life for patients
Thymic tumors
Thymic tumors are rare cancers originating in the thymus gland, located in the upper chest. They include thymomas, which grow slowly, and thymic carcinomas, which are more aggressive. New treatments, such as targeted therapy and immunotherapy, are being investigated to improve outcomes for patients with advanced thymic tumors

Testimonials
What Our Patients Are Saying

On meeting Dr Papadatos for the first time he recommended I stay on the immunotherapy treatment. I have since been undergoing the treatment every 6 weeks and so far I am responding well with very little side effects. Dr Papadatos explained everything fully to me and has a very reassuring, confidant manor. He seems like a very nice pleasant man who I fully trust. He listened to my questions and answered them thoroughly. If it was possible I would recommend Dr Papadatos to anyone needing the care of an oncologist.

As seen in iwantgreatcare

Dr Papadatos-Pastos Is the most amazing oncologist, he makes you feel you are in safe hands always, he listens to your questions and answers you in a way you can understand. He has been my oncologist for the past 3 years, and I trust him with my life. Couldn’t recommend him any higher.

As seen in iwantgreatcare

Dr Papadatos-Pastos is an excellent doctor. I found him very open, caring, gentle and warm. He made me feel positive and hopeful. Apart from being a skilled oncologist he made a great impact on me. Under his treatment I am doing very well.
I wish him all the best.

As seen in iwantgreatcare

Very pleased with the consultation. He took the time to answer all questions. I’d highly recommend.

As seen in topdoctors

Dr Dionysis Papadatos-Pastos gives useful explanation and satisfactory advise.

As seen in topdoctors


Understanding ALK-Driven Non-Small Cell Lung Cancer (NSCLC)
Anaplastic Lymphoma Kinase (ALK)-driven non-small cell lung cancer (NSCLC) is a subtype of lung cancer...
New Hope for B3 Thymoma and Thymic Carcinoma: Promising Results from Multi Targeted Therapy and Immunotherapy Combination Therapy
The PECATI trial, presented at ESMO 2024, brings promising news for patients with advanced B3...
Early stage small cell lung cancer
The treatment of early-stage small cell lung cancer (SCLC) has traditionally involved a combination of...
Treatment of ROS1-Driven Lung Cancer: A Comprehensive Overview
Lung cancer remains one of the most common and lethal cancers worldwide, but advances in...
Targeted therapies in NSCLC
Targeted therapies have revolutionized the treatment of non-small cell lung cancer (NSCLC), offering more personalized...
Why surgery should not be routinely used in patients with mesothelioma
The MARS2 trial (Mesothelioma and Radical Surgery 2) was designed to evaluate the effectiveness of...
Advanced stage small cell lung cancer
Extensive-stage small cell lung cancer (SCLC) is a challenging diagnosis, as it indicates the cancer...
Clinical trials
Clinical trials are crucial in advancing lung cancer treatment, offering patients access to cutting-edge therapies...
Recent Advances in the Treatment of EGFR (common mutations)-Driven Non-Small Cell Lung Cancer (NSCLC)
Lung cancer is one of the most common and deadliest cancers worldwide, and about 85%...
Immunotherapy in NSCLC
Immunotherapy has transformed the treatment landscape for non-small cell lung cancer (NSCLC), offering new hope,...

Media
To intensify or not to intensify 1L treatment in EGFR-Mutated NSCLC?
Resources for physicians: Dr Papadatos-Pastos presentation on 1st line treatment for EGFR driven non small...
Dr Papadatos-Pastos in the Evening Standard (10 September 2024)
Hopeful horizons for lung cancer patients As seen in the Evening Standard newspaper on September...
Dr. Dionysis Papadatos-Pastos and Dr. Liz O’Riordan share their insights on the claims and dangers of ‘natural cancer cures’ as portrayed in the Netflix series Apple Cider Vinegar
14 February 2025 Is Hirsch therapy seen in Netflix’s Apple Cider Vinegar real? Milla in...
Discussing Antibody Drug Conjugates in NSCLC
Resources for physicians: Discussing Antibody Drug Conjugates in NSCLCResources for physicians: Dr Papadatos-Pastos presentation on...
Dr Papadatos-Pastos at the 5th International Meeting on Lung Cancer
The 5th International Meeting on Lung Cancer was a highly successful event, bringing together leading...
Dr Papadatos-Pastos in The London Clinic Lung Cancer Awareness Month (November 2024)
A common misconception of Lung Cancer is that it’s just a smoker’s disease. Whilst smoking...
New Year New You ’ distributed with The Guardian 4th January 2025
Better recovery for lungcancer 2025 New Year New You ’ distributed with The Guardian 4th...
New Hope for Oligometastatic Non-Small Cell Lung Cancer: Breakthrough Treatments in 2025 Bringing Patients Closer to Long-Term Survival
At the 1st Cyprus Oncology Conference in Nicosia, Dr. Papadatos-Pastos delivered a compelling presentation on...